Form 4: Doximity Director Sells Shares Under 10b5-1 Plan

A Doximity director converted Class B shares to Class A and sold a portion of Class A shares under a pre-arranged trading plan.

Summary

• Kira Scherer Wampler, a Director at Doximity, Inc., engaged in several transactions on January 2, 2026.
• Exercised stock options to acquire 2,000 shares of Class B Common Stock with an exercise price of $1.54 per share.
• Converted 2,000 shares of Class B Common Stock into 2,000 shares of Class A Common Stock.
• Sold 2,000 shares of Class A Common Stock at a price of $44.65 per share.
• The sale was executed automatically under a Rule 10b5-1 trading plan adopted on November 12, 2024.
• Following these transactions, the reporting person beneficially owns 19,839 shares of Class A Common Stock and 460,700 stock options for Class B Common Stock.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction filing (Form 4) reporting the exercise of options, conversion of shares, and sale of shares under a pre-arranged 10b5-1 trading plan. It does not inherently indicate positive or negative sentiment about the company's future prospects.

Risks

• The existence of Class B Common Stock with specific conversion rules and automatic conversion triggers could introduce complexity in the company's capital structure.
• Future sales by insiders under 10b5-1 plans, while pre-scheduled, could potentially impact market perception or share price.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing (Form 4) for a director of Doximity, Inc., a digital platform for medical professionals. Such filings are common across all publicly traded companies and reflect individual compensation and portfolio management rather than broader industry trends.

Comparison to Industry Standards

• This is a standard insider transaction report. There are no specific comparable companies or projects to list as the filing details a personal transaction by a director, not company performance.
• The transaction, being executed under a Rule 10b5-1 plan, aligns with best practices for insiders to avoid accusations of trading on material non-public information.

Corporate Governance

Stakeholder Impact

• Shareholders: The sale of shares by a director, even under a 10b5-1 plan, could be perceived by some as a lack of confidence, though it is a common practice for liquidity and diversification. The dual-class structure impacts voting rights.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where a director exercised options, converted shares, and sold a portion of Class A stock under a pre-arranged 10b5-1 plan. Such transactions are common for liquidity and diversification and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing provides no new information to alter an existing investment thesis.

Keywords

Doximity, DOCS, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Director, Equity Transaction, Class A Common Stock, Class B Common Stock, Stock Options